Calcium Lactate Loading Limits in Aqueous Oral Suspensions

Because calcium lactate pentahydrate dissolves at approximately 7.9 g/100 mL in water at 25 °C, the distinction between a thermodynamically stable solution and a suspended oral dosage form becomes critical at elemental calcium doses exceeding roughly 10.3 mg/mL. The pentahydrate salt has a molecular weight of 308.30 g/mol, yielding a calcium content of 13.0% w/w; therefore, a saturated aqueous solution contains 79 mg/mL of the salt and 10.27 mg/mL of elemental calcium. Above this concentration, undissolved calcium lactate particles must be physically stabilized by suspending agents, because the aqueous phase cannot accommodate additional solute without risking crystal growth on cooled storage surfaces, dose non-uniformity, and syringe blockage. The equilibrium solubility is temperature dependent, but published data for solubility in multi-component oral vehicles containing sorbitol, glycerin, sucrose, or propylene glycol remain limited; industrial formulation work therefore relies on ternary or quaternary phase measurements rather than binary water-salt solubility data. The lactic acid portion has a pKa of 3.86 at 25 °C; aqueous solutions of calcium lactate typically exhibit pH 6.0–8.0, which places the system in a pH range where weak-acid preservatives such as benzoic acid lose antimicrobial activity. This pH constraint determines whether the formulation can be preserved with sodium benzoate at 0.1–0.2% w/v or must be moved to a paraben-based preservative system validated under USP <51>.

The regulatory status of calcium lactate under 21 CFR 184.1207 establishes GRAS status for direct food use, but pharmaceutical oral suspensions must additionally meet USP <795> for nonsterile compounding or USP <1151> for dosage form design. Loading limits are not defined solely by chemical solubility; the practical ceiling is reached when the suspended solids fraction raises yield stress, sedimentation volume, and extrusion force beyond the limits of the intended dosing device. Incoming raw material lot-to-lot variability compounds the problem. Calcium lactate pentahydrate lots from different manufacturers vary in crystal habit, residual moisture, and particle size distribution. A lot received as needle-like crystals with D90 of 180 µm will not behave identically to a milled lot with D90 of 80 µm when both are dispersed at the same 15% w/v loading. Therefore, incoming material must be tested by USP <429> or ISO 13320 before batching. The theoretical water content of the pentahydrate is 29.2%; if material is overdried during storage, partial dehydration to calcium lactate monohydrate or anhydrous form changes the calcium content per unit mass. Loss on drying should be measured according to the calcium lactate monograph and the charge weight adjusted on the basis of assay rather than nominal pentahydrate formula weight. The absence of such adjustment is a common batch-to-batch potency failure when compounding at maximal loading.

What Limits the Maximum Non-Settling Loading in Xanthan-Stabilized Suspensions?

In vehicles thickened with xanthan gum at 0.20–0.80% w/v, the practical loading limit is governed less by thermodynamic solubility than by yield stress and sedimentation volume ratio. Xanthan gum develops a yield stress that supports suspended calcium lactate particles when hydrated to full viscosity under high-shear dispersion; however, calcium ions can compress the electrical double layer and reduce the electrostatic repulsion that stabilizes particles, shifting the suspension from a dispersed state to a weakly flocculated network. Rotational rheometry according to ISO 3219 or ASTM D2196 is used to measure apparent viscosity at 50 s⁻¹; oral suspensions intended for dosing cups or oral syringes generally require 500–2000 mPa·s at 25 °C. Total calcium lactate pentahydrate loadings above approximately 150–200 mg/mL in 0.35% w/v xanthan gum vehicles show sedimentation volume ratios below 0.80 after 24 h, but published data for this specific configuration is limited. The failure mode is not necessarily caking; rather, the ratio of sediment height to total suspension height decreases as the particle volume fraction exceeds the yield-stress capacity of the polymer network. On production-scale vessels, a side-scraping anchor agitator operating at 10–30 rpm is paired with a high-shear rotor-stator mixer such as a Silverson L5M-A operating at tip speeds of 10–25 m/s for 10–20 min. Xanthan gum should be dispersed in glycerin before water addition to avoid fish-eye aggregates; hydration times shorter than 60 min result in viscosity drift from batch to batch and unstable sediment volumes.

Rheological Characterization and Syringeability Boundaries at High Calcium Lactate Volume Fractions

Rotational rheometry and syringe extrusion force measurements become decisive when calcium lactate pentahydrate loading exceeds 200 mg/mL in vehicles containing microcrystalline cellulose/carboxymethylcellulose sodium at 1.0–1.5% w/v or xanthan gum at 0.4–0.6% w/v. The material typically exhibits a Herschel-Bulkley yield stress; as particle volume fraction increases, the apparent yield stress rises exponentially rather than linearly. Syringeability is evaluated by measuring the extrusion force of a 5 mL oral syringe with a tip internal diameter of 2 mm; forces above 20 N are generally considered unacceptable for pediatric dosing, but the acceptance boundary must be set by the intended patient population and validated with a dosing device compliant with ISO 80369-3. Particle size distribution measured by USP <429> or ISO 13320 should be controlled at D90 not exceeding 150 µm for oral syringes; larger particles bridge the nozzle and cause variability in delivered dose. The use of a cone mill such as a Comil U5 with a 0.5–1.5 mm screen at 1000–4000 rpm after blending reduces oversized calcium lactate crystals but may increase fines; excessive fines then raise low-shear viscosity and create dusting during powder transfer. If the manufacturing suite exceeds 60% RH, calcium lactate pentahydrate powder absorbs moisture and clumps during screening; therefore a humidity-controlled dispensing booth or pre-drying step is required before milling and blending.

When Calcium Lactate Pentahydrate Is Loaded Above 150 mg/mL in Sorbitol-Glycerin Vehicles

When sorbitol solution 70% w/w and glycerin are used in combination to improve mouthfeel and reduce crystallization, the solvent environment no longer behaves as pure water; water activity falls, but calcium lactate solubility does not decline in a simple linear manner. Published data for solubility in sorbitol-glycerin-water mixtures of defined composition is limited, so the formulation must be treated as a ternary or quaternary system and measured directly by gravimetric or HPLC assay. A production-scale danger occurs when the vehicle is warmed to 40–45 °C during high-shear dispersion to reduce viscosity; salt dissolved at that temperature may supersaturate the cooler filling line at 20–25 °C, causing slow crystal growth and gritty mouthfeel after 24–48 h. Accelerated stability at 40 °C/75% RH per ICH Q1A(R2) should therefore include both total assay and particle size change, because chemical potency may remain within 90.0–110.0% while physical instability renders the product unacceptable. The critical processing window is narrow: holding the batch at 25–30 °C during suspension preparation and filling avoids temperature cycling but increases viscosity and air entrainment; reducing viscosity by adding water may push calcium lactate below the intended dose per 5 mL. Vacuum deaeration at -0.8 to -0.95 bar for 30–60 min after high-shear mixing removes entrained air. If deaeration is omitted, filled volume variation can exceed ±2% against the label claim because air bubbles occupy headspace. Filled containers should be checked for deliverable volume under USP <698> and the redispersibility of settled sediment after storage at 5 °C and 40 °C must be included in the stability protocol.

Preservation of high-load calcium lactate suspensions must be validated with USP <51> because the water activity generally remains above 0.85, supporting the growth of Pseudomonas aeruginosa, Burkholderia cepacia, and yeast unless an effective preservative system is included. Antimicrobial effectiveness acceptance requires bacterial reduction of not less than 1.0 log at 7 days, not less than 3.0 log at 14 days, and no increase at 28 days; yeast and mold show no increase from the initial count. Because the pH of a calcium lactate suspension is typically 6.0–8.0, sodium benzoate at 0.1–0.2% w/v may be insufficient; benzoic acid has a pKa of 4.19 and loses activity above pH 5.5. Paraben esters such as methylparaben 0.1–0.2% w/v and propylparaben 0.01–0.02% w/v retain activity in neutral pH but can partition into flavor oils and plastic packaging. Potassium sorbate at 0.1–0.2% w/v is effective up to pH 6.5 and may be combined with a paraben system. No preservative claim is acceptable without a USP <51> challenge at the lowest intended use concentration and at the end of the proposed beyond-use date.

The Solubility Product of Calcium Phosphate Sets a Hard Incompatibility Boundary

Aqueous vehicles containing phosphate buffers or citrate buffers must be avoided when calcium lactate is loaded above saturated solution levels because insoluble calcium phosphate or calcium citrate can form. The solubility product of tricalcium phosphate is exceptionally low, and even traces of phosphate from flavors or preservatives can form precipitates that appear as white specks in the suspension. Sodium alginate and pectin are unsuitable as suspending agents at high calcium loading because calcium ions bridge carboxylate groups on adjacent polymer chains and cause gelation or syneresis; if alginate is required for other reasons, sequestering calcium and re-checking yield stress after 24 h under ISO 3219 is mandatory. Carboxymethylcellulose sodium and microcrystalline cellulose are less sensitive to calcium but can still lose viscosity if ionic strength exceeds 0.1 mol/L. The use of EDTA at 0.01–0.05% w/v as a chelating agent can mask calcium ions, but it also alters the bioavailable calcium fraction and must be justified by total assay and any dissolution specification that applies to the dosage form.

Citric acid is often added to mask the chalky taste of calcium lactate, but citrate ion complexes calcium and reduces free calcium in solution. If citric acid is added at 0.05–0.15% w/v, the formulation must be assayed for dissolved calcium and checked for particle size shift after 24 h. Artificial sweeteners such as sucralose or acesulfame potassium are preferred over sucrose in high-load suspensions because sucrose reduces the available water and may crystallize at the container neck during repeated opening. The suspension should be stored in a well-closed container; moisture loss through the closure can increase concentration and cause salt crystallization at the thread area. Piston-pump filling lines require a nozzle internal diameter of at least 3 mm for suspensions containing calcium lactate particles with D90 up to 150 µm; smaller nozzles create shear-induced particle alignment and clogging during intermittent filling. A product hopper with continuous low-shear agitation at 10–30 rpm helps maintain uniformity, but air incorporation must be checked because high-load suspensions with yield stress do not release air quickly without vacuum.